Marc G. Besselink

59.7k total citations · 9 hit papers
751 papers, 19.4k citations indexed

About

Marc G. Besselink is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Marc G. Besselink has authored 751 papers receiving a total of 19.4k indexed citations (citations by other indexed papers that have themselves been cited), including 538 papers in Oncology, 517 papers in Surgery and 274 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Marc G. Besselink's work include Pancreatic and Hepatic Oncology Research (514 papers), Pancreatitis Pathology and Treatment (324 papers) and Gallbladder and Bile Duct Disorders (185 papers). Marc G. Besselink is often cited by papers focused on Pancreatic and Hepatic Oncology Research (514 papers), Pancreatitis Pathology and Treatment (324 papers) and Gallbladder and Bile Duct Disorders (185 papers). Marc G. Besselink collaborates with scholars based in Netherlands, United States and Italy. Marc G. Besselink's co-authors include Hjalmar C. van Santvoort, Olivier R. Busch, Hein G. Gooszen, Thomas L. Bollen, Casper H.J. van Eijck, Marja A. Boermeester, Olaf J. Bakker, Marco J. Bruno, Bas Groot Koerkamp and Thomas M. van Gulik and has published in prestigious journals such as The Lancet, JAMA and Journal of Clinical Oncology.

In The Last Decade

Marc G. Besselink

690 papers receiving 19.0k citations

Hit Papers

Acute pancreatitis 2012 2026 2016 2021 2020 2012 2018 2017 2020 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Acute pancreatitis
    2020 593 citations Lotte Boxhoorn, Rogier P. Voermans et al. profile →
  2. Endoscopic Transgastric vs Surgical Necrosectomy for Infected Necrotizing Pancreatitis
    2012 463 citations Hjalmar C. van Santvoort, Marc G. Besselink et al. profile →
  3. Meta-analysis comparing upfront surgery with neoadjuvant treatment in patients with resectable or borderline resectable pancreatic cancer
    2018 349 citations Eva Versteijne, Jantien A. Vogel et al. profile →
  4. Acute pancreatitis: recent advances through randomised trials
    2017 299 citations Hjalmar C. van Santvoort, Marco J. Bruno et al. Gut profile →
  5. Guidelines for Perioperative Care for Pancreatoduodenectomy: Enhanced Recovery After Surgery (ERAS) Recommendations 2019
    2020 284 citations Marc G. Besselink, Cornelis H.C. Dejong et al. profile →
  6. Impact of characteristics of organ failure and infected necrosis on mortality in necrotising pancreatitis
    2018 276 citations Marc G. Besselink, Thomas L. Bollen et al. Gut profile →
  7. Current Concepts in Severe Acute and Necrotizing Pancreatitis: An Evidence-Based Approach
    2019 238 citations Hjalmar C. van Santvoort, Martin L. Freeman et al. profile →
  8. Preoperative chemotherapy, radiotherapy and surgical decision-making in patients with borderline resectable and locally advanced pancreatic cancer
    2023 83 citations Thomas F. Stoop, Leonard W. F. Seelen et al. profile →
  9. Pancreatic cancer
    2025 31 citations Thomas F. Stoop, Bas Groot Koerkamp et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marc G. Besselink Netherlands 71 13.5k 12.8k 6.9k 2.3k 1.4k 751 19.4k
Henry A. Pitt United States 85 19.1k 1.4× 16.1k 1.3× 13.1k 1.9× 4.9k 2.1× 1.2k 0.9× 471 27.0k
Claudio Bassi Italy 72 25.6k 1.9× 27.6k 2.2× 14.4k 2.1× 6.9k 3.0× 2.1k 1.5× 500 37.0k
Andrew L. Warshaw United States 91 20.3k 1.5× 20.2k 1.6× 7.0k 1.0× 6.4k 2.8× 2.2k 1.6× 467 31.4k
Mark A. Talamini United States 58 10.0k 0.7× 4.9k 0.4× 5.7k 0.8× 1.6k 0.7× 396 0.3× 306 14.6k
Paris Tekkis United Kingdom 79 13.8k 1.0× 12.1k 0.9× 3.9k 0.6× 2.7k 1.2× 530 0.4× 397 21.6k
Dirk J. Gouma Netherlands 67 14.6k 1.1× 13.5k 1.1× 9.4k 1.4× 2.7k 1.2× 689 0.5× 273 19.8k
Richard D. Schulick United States 86 17.3k 1.3× 19.7k 1.5× 10.6k 1.5× 6.1k 2.6× 3.3k 2.3× 347 32.7k
Robert W. Beart United States 78 15.1k 1.1× 9.0k 0.7× 4.8k 0.7× 1.6k 0.7× 579 0.4× 355 22.0k
Marco J. Bruno Netherlands 64 11.1k 0.8× 8.4k 0.7× 5.6k 0.8× 1.8k 0.8× 1.3k 0.9× 481 16.3k
T. Peter Kingham United States 60 5.5k 0.4× 6.7k 0.5× 3.4k 0.5× 1.5k 0.7× 952 0.7× 413 11.9k

Countries citing papers authored by Marc G. Besselink

Since Specialization
Citations

This map shows the geographic impact of Marc G. Besselink's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc G. Besselink with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc G. Besselink more than expected).

Fields of papers citing papers by Marc G. Besselink

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc G. Besselink. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc G. Besselink. The network helps show where Marc G. Besselink may publish in the future.

Co-authorship network of co-authors of Marc G. Besselink

This figure shows the co-authorship network connecting the top 25 collaborators of Marc G. Besselink. A scholar is included among the top collaborators of Marc G. Besselink based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marc G. Besselink. Marc G. Besselink is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Timmerhuis, Hester C., Lotte Boxhoorn, Rogier P. Voermans, et al.. (2025). Predictors for Successful Treatment of Infected Necrotizing Pancreatitis With Antibiotics Alone. Annals of Surgery. 282(5). 860–867.
2.
Besselink, Marc G., et al.. (2025). Robotic versus laparoscopic liver resection: a systematic review and meta-analysis of comparative studies. International Journal of Surgery. 111(8). 5549–5571. 3 indexed citations
3.
Varghese, Chris, William Xu, Cameron I. Wells, et al.. (2024). Systematic Review of Volume and Methodological Quality of Randomized Trials in Acute Pancreatitis. Pancreas. 54(2). e82–e88.
4.
Schouten, Thijs J., Lois A. Daamen, Leonard W. F. Seelen, et al.. (2024). Evaluation of Short and Long-term Outcomes After Resection in Patients With Locally Advanced Versus (Borderline) Resectable Pancreatic Cancer. Annals of Surgery. 281(6). 1026–1031. 1 indexed citations
5.
Sprangers, Mirjam A. G., Konstantinos Pateras, A. Bruynzeel, et al.. (2023). Impact of Short-Course Palliative Radiation Therapy on Pancreatic Cancer-Related Pain: Prospective Phase 2 Nonrandomized PAINPANC Trial. International Journal of Radiation Oncology*Biology*Physics. 118(2). 352–361. 5 indexed citations
6.
Stoop, Thomas F., Sebastian Hempel, Susan van Dieren, et al.. (2023). Systematic Review and Meta-analysis of the Role of Total Pancreatectomy as an Alternative to Pancreatoduodenectomy in Patients at High Risk for Postoperative Pancreatic Fistula. Annals of Surgery. 278(4). e702–e711. 15 indexed citations
7.
Mazzotta, Alessandro, Eduard A. van Bodegraven, Niccolò Petrucciani, et al.. (2023). Oncological Outcome After Laparoscopic ‘No-touch’ RAMPSVersus‘Touch’ Left Pancreatectomy for Pancreatic Adenocarcinoma. Anticancer Research. 43(11). 4983–4991.
8.
Korrel, Maarten, Jony van Hilst, Koop Bosscha, et al.. (2023). Nationwide use and Outcome of Minimally Invasive Distal Pancreatectomy in IDEAL Stage IV following a Training Program and Randomized Trial. Annals of Surgery. 279(2). 323–330. 1 indexed citations
9.
Schuurman, Melinda S., Dorothea Wagner, Judith de Vos‐Geelen, et al.. (2022). Sex, Gender and Age Differences in Treatment Allocation and Survival of Patients With Metastatic Pancreatic Cancer: A Nationwide Study. Frontiers in Oncology. 12. 839779–839779. 14 indexed citations
10.
Buettner, Stefan, Marc G. Besselink, Olivier R. Busch, et al.. (2021). Surgical morbidity in the first year after resection for perihilar cholangiocarcinoma. HPB. 23(10). 1607–1614. 11 indexed citations
11.
Janssen, Quisette P., Marc G. Besselink, Bert A. Bonsing, et al.. (2021). Real‐world evidence of adjuvant gemcitabine plus capecitabine vs gemcitabine monotherapy for pancreatic ductal adenocarcinoma. International Journal of Cancer. 150(10). 1654–1663. 10 indexed citations
12.
Dam, Jacob L. van, Jesse V. Groen, Casper H.J. van Eijck, et al.. (2020). Pancreatic resection in the pediatric, adolescent and young adult population: nationwide analysis on complications. HPB. 23(8). 1175–1184. 6 indexed citations
13.
Strijker, Marin, Tara M. Mackay, Bert A. Bonsing, et al.. (2020). Establishing and Coordinating a Nationwide Multidisciplinary Study Group: Lessons Learned by the Dutch Pancreatic Cancer Group. Annals of Surgery. 271(4). e102–e104. 31 indexed citations
14.
Latenstein, Anouk E.J., Stijn van Roessel, Lydia G. van der Geest, et al.. (2020). Conditional Survival After Resection for Pancreatic Cancer: A Population-Based Study and Prediction Model. Annals of Surgical Oncology. 27(7). 2516–2524. 52 indexed citations
15.
Drewes, Asbjørn Mohr, Marinus A. Kempeneers, Dana K. Andersen, et al.. (2019). Controversies on the endoscopic and surgical management of pain in patients with chronic pancreatitis: pros and cons!. Gut. 68(8). 1343–1351. 44 indexed citations
16.
Vogel, Jantien A., Eran van Veldhuisen, Lindy K. Alles, et al.. (2019). Time-Dependent Impact of Irreversible Electroporation on Pathology and Ablation Size in the Porcine Liver: A 24-Hour Experimental Study. Technology in Cancer Research & Treatment. 18. 1078144547–1078144547. 18 indexed citations
17.
Strijker, Marin, Lydia G. van der Geest, Thomas M. van Gulik, et al.. (2019). Treatment and survival of resected and unresected distal cholangiocarcinoma: a nationwide study. Acta Oncologica. 58(7). 1048–1055. 78 indexed citations
18.
Rassam, Fadi, Pim B. Olthof, Krijn P. van Lienden, et al.. (2018). Functional and volumetric assessment of liver segments after portal vein embolization: Differences in hypertrophy response. Surgery. 165(4). 686–695. 22 indexed citations
19.
20.
Besselink, Marc G., et al.. (2014). Infected necrotising pancreatitis with associated emphysematous cholecystitis and pneumobilia. Pure Amsterdam UMC. 18(6). 23–25. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Henry A. Pitt Breakdown of academic impact, for papers by Claudio Bassi Breakdown of academic impact, for papers by Andrew L. Warshaw Breakdown of academic impact, for papers by Mark A. Talamini Breakdown of academic impact, for papers by Paris Tekkis Breakdown of academic impact, for papers by Dirk J. Gouma Breakdown of academic impact, for papers by Richard D. Schulick Breakdown of academic impact, for papers by Robert W. Beart Breakdown of academic impact, for papers by Marco J. Bruno Breakdown of academic impact, for papers by T. Peter Kingham
Rankless by CCL
2026